Adage Capital Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-614,455
| Closed | -$529K | – | 819 |
|
|
2019
Q4 | $529K | Hold |
614,455
| – | – | ﹤0.01% | 696 |
|
|
2019
Q3 | $344K | Hold |
614,455
| – | – | ﹤0.01% | 705 |
|
|
2019
Q2 | $320K | Hold |
614,455
| – | – | ﹤0.01% | 698 |
|
|
2019
Q1 | $277K | Hold |
614,455
| – | – | ﹤0.01% | 680 |
|
|
2018
Q4 | $295K | Hold |
614,455
| – | – | ﹤0.01% | 699 |
|
|
2018
Q3 | $326K | Hold |
614,455
| – | – | ﹤0.01% | 704 |
|
|
2018
Q2 | $307K | Hold |
614,455
| – | – | ﹤0.01% | 721 |
|
|
2018
Q1 | $260K | Hold |
614,455
| – | – | ﹤0.01% | 712 |
|
|
2017
Q4 | $233K | Hold |
614,455
| – | – | ﹤0.01% | 694 |
|
|
2017
Q3 | $221K | Hold |
614,455
| – | – | ﹤0.01% | 706 |
|
|
2017
Q2 | $233K | Hold |
614,455
| – | – | ﹤0.01% | 699 |
|
|
2017
Q1 | $277K | Hold |
614,455
| – | – | ﹤0.01% | 694 |
|
|
2016
Q4 | $233K | Hold |
614,455
| – | – | ﹤0.01% | 681 |
|
|
2016
Q3 | $166K | Hold |
614,455
| – | – | ﹤0.01% | 679 |
|
|
2016
Q2 | $147K | Hold |
614,455
| – | – | ﹤0.01% | 679 |
|
|
2016
Q1 | $70K | Hold |
614,455
| – | – | ﹤0.01% | 683 |
|
|
2015
Q4 | $69K | Hold |
614,455
| – | – | ﹤0.01% | 684 |
|
|
2015
Q3 | $117K | Hold |
614,455
| – | – | ﹤0.01% | 708 |
|
|
2015
Q2 | $430K | Hold |
614,455
| – | – | ﹤0.01% | 715 |
|
|
2015
Q1 | $417K | Hold |
614,455
| – | – | ﹤0.01% | 703 |
|
|
2014
Q4 | $485K | Hold |
614,455
| – | – | ﹤0.01% | 698 |
|
|
2014
Q3 | $286K | Hold |
614,455
| – | – | ﹤0.01% | 702 |
|
|
2014
Q2 | $307K | Hold |
614,455
| – | – | ﹤0.01% | 684 |
|
|
2014
Q1 | $190K | Hold |
614,455
| – | – | ﹤0.01% | 673 |
|
|
2013
Q4 | $209K | Sell |
614,455
-790,000
| -56% | -$955K | ﹤0.01% | 671 |
|
|
2013
Q3 | $2.84M | Hold |
1,404,455
| – | – | 0.01% | 629 |
|
|
2013
Q2 | $2.67M | Buy |
+1,404,455
| New | +$2.47M | 0.01% | 631 |
|
Adage Capital Partners's GCVRZ Position: Q1 2020 in Review
Adage Capital Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 614,455 shares — an estimated $529K sold.
Adage Capital Partners first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $2.84M in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Adage Capital Partners reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Adage Capital Partners sold 614,455 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $529K.
- Adage Capital Partners first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Adage Capital Partners's Sanofi Contingent Value Rights position peaked at $2.84M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Adage Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.